How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,432 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

28241. Prevention of corticosteroid induced osteoporosis : Should be easier if doctors follow the recent guidelines  Full Text available with Trip Pro

Prevention of corticosteroid induced osteoporosis : Should be easier if doctors follow the recent guidelines  10334726 1999 06 25 2018 11 13 0959-8138 318 7195 1999 May 22 BMJ (Clinical research ed.) BMJ Prevention of corticosteroid induced osteoporosis. 1366-7 Lips P P eng Editorial England BMJ 8900488 0959-8138 0 Adrenal Cortex Hormones AIM IM BMJ. 1999 Sep 4;319(7210):643 10473492 Adrenal Cortex Hormones adverse effects Humans Osteoporosis chemically induced prevention & control Practice (...) Guidelines as Topic 1999 5 20 1999 5 20 0 1 1999 5 20 0 0 ppublish 10334726 PMC1115759 N Engl J Med. 1993 Jun 17;328(24):1747-52 7684512 Arthritis Rheum. 1994 Oct;37(10):1499-505 7945476 Arch Intern Med. 1996 Jun 10;156(11):1173-7 8639011 BMJ. 1996 Aug 10;313(7053):344-6 8760745 J Clin Endocrinol Metab. 1996 Oct;81(10):3441-7 8855781 N Engl J Med. 1997 Aug 7;337(6):382-7 9241127 N Engl J Med. 1998 Jul 30;339(5):292-9 9682041 J Intern Med. 1998 Oct;244(4):271-92 9797491

1999 BMJ : British Medical Journal

28242. Antenatal corticosteroids to prevent neonatal respiratory distress syndrome : We do not know whether repeated doses are better than a single dose Full Text available with Trip Pro

Antenatal corticosteroids to prevent neonatal respiratory distress syndrome : We do not know whether repeated doses are better than a single dose 10657305 2000 03 09 2018 11 13 0959-8138 320 7231 2000 Feb 05 BMJ (Clinical research ed.) BMJ Antenatal corticosteroids to prevent neonatal respiratory distress syndrome. We do not know whether repeated doses are better than a single dose. 325-6 Spencer C C Neales K K eng Editorial England BMJ 8900488 0959-8138 0 Adrenal Cortex Hormones AIM IM BMJ (...) . 2000 Jul 1;321(7252):47 10939812 Adrenal Cortex Hormones administration & dosage Female Humans Infant, Newborn Multicenter Studies as Topic Pregnancy Prenatal Care methods Randomized Controlled Trials as Topic Respiratory Distress Syndrome, Newborn prevention & control 2000 2 5 9 0 2000 3 11 9 0 2000 2 5 9 0 ppublish 10657305 PMC1127120 Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F213-6 10212084 Br J Obstet Gynaecol. 1999 Sep;106(9):977-9 10492112 Obstet Gynecol. 1997 Nov;90(5):819-23 9351771

2000 BMJ : British Medical Journal

28243. Corticosteroids in rheumatoid arthritis: Effective anti-inflammatory agents but doubts about safety remain Full Text available with Trip Pro

Corticosteroids in rheumatoid arthritis: Effective anti-inflammatory agents but doubts about safety remain 9549442 1998 04 29 2018 11 13 0959-8138 316 7134 1998 Mar 14 BMJ (Clinical research ed.) BMJ Corticosteroids in rheumatoid arthritis. 789-90 Dennison E M EM Cooper C C eng Comment Editorial England BMJ 8900488 0959-8138 0 Adrenal Cortex Hormones 0 Anti-Inflammatory Agents 9PHQ9Y1OLM Prednisolone AIM IM BMJ. 1998 May 23;316(7144):1606-7 9596608 BMJ. 1998 Mar 14;316(7134):811-8 9549450 (...) Adrenal Cortex Hormones administration & dosage adverse effects Aged Anti-Inflammatory Agents administration & dosage adverse effects Arthritis, Rheumatoid drug therapy Humans Meta-Analysis as Topic Middle Aged Prednisolone administration & dosage adverse effects 1998 4 29 1998 4 29 0 1 1998 4 29 0 0 ppublish 9549442 PMC1112762 Br J Rheumatol. 1995 Apr;34(4):347-51 7788149 Arch Intern Med (Chic). 1950 Apr;85(4):545-666 15411248 Hosp Pract (Off Ed). 1983 Sep;18(9):137-41, 145-6 6411587 Br J Rheumatol

1998 BMJ : British Medical Journal

28244. Higher dose inhaled corticosteroids in childhood asthma : What we do doesn't work and what we don't do does Full Text available with Trip Pro

Higher dose inhaled corticosteroids in childhood asthma : What we do doesn't work and what we don't do does 11230052 2001 04 05 2018 11 13 0959-8138 322 7285 2001 Mar 03 BMJ (Clinical research ed.) BMJ Higher dose inhaled corticosteroids in childhood asthma. 504-5 Keeley D D eng Editorial England BMJ 8900488 0959-8138 0 Glucocorticoids AIM IM BMJ. 2001 Jun 23;322(7301):1546 11439999 BMJ. 2001 Jun 23;322(7301):1546 11439998 Administration, Inhalation Administration, Oral Adolescent Asthma drug (...) therapy Child Child, Preschool Drug Administration Schedule Evidence-Based Medicine Glucocorticoids administration & dosage Humans Randomized Controlled Trials as Topic 2001 3 7 10 0 2001 4 6 10 1 2001 3 7 10 0 ppublish 11230052 PMC1119722 Ann Emerg Med. 1995 Oct;26(4):480-6 7574132 Acta Paediatr. 1999 Aug;88(8):835-40 10503681 J Paediatr Child Health. 1999 Oct;35(5):483-7 10571764 Cochrane Database Syst Rev. 2000;(3):CD002308 10908552 N Engl J Med. 2000 Sep 7;343(10):689-94 10974132 J Allergy Clin

2001 BMJ : British Medical Journal

28245. Respiratory distress syndrome and antenatal corticosteroid treatment in premature twins Full Text available with Trip Pro

Respiratory distress syndrome and antenatal corticosteroid treatment in premature twins 11455946 2001 08 02 2010 12 22 1359-2998 85 1 2001 Jul Archives of disease in childhood. Fetal and neonatal edition Arch. Dis. Child. Fetal Neonatal Ed. Respiratory distress syndrome and antenatal corticosteroid treatment in premature twins. F77-8 Hacking D D Watkins A A Fraser S S Wolfe R R Nolan T T eng Letter England Arch Dis Child Fetal Neonatal Ed 9501297 1359-2998 0 Glucocorticoids AIM IM Diseases (...) in Twins Female Glucocorticoids therapeutic use Humans Infant, Newborn Infant, Premature Pregnancy Prenatal Exposure Delayed Effects Randomized Controlled Trials as Topic Respiratory Distress Syndrome, Newborn prevention & control Treatment Outcome 2001 7 18 10 0 2001 8 3 10 1 2001 7 18 10 0 ppublish 11455946 PMC1721283

2001 Archives of Disease in Childhood. Fetal and Neonatal Edition

28246. Corticosteroids in acute traumatic brain injury. Full Text available with Trip Pro

Corticosteroids in acute traumatic brain injury. 9487200 1998 03 06 2016 11 24 0959-8138 316 7128 1998 Jan 31 BMJ (Clinical research ed.) BMJ Corticosteroids in acute traumatic brain injury. 396 Newell D W DW Temkin N R NR Bullock R R Choi S S eng Letter Comment England BMJ 8900488 0959-8138 0 Adrenal Cortex Hormones 0 Neuroprotective Agents 0 Pregnatrienes YD064E883I tirilazad AIM IM BMJ. 1997 Jun 28;314(7098):1855-9 9224126 Adrenal Cortex Hormones therapeutic use Brain Injuries drug therapy (...) Humans Neuroprotective Agents therapeutic use Pregnatrienes therapeutic use Randomized Controlled Trials as Topic Treatment Outcome 1998 3 6 1998 3 6 0 1 1998 3 6 0 0 ppublish 9487200 PMC2665529

1998 BMJ : British Medical Journal

28247. Low dose inhaled corticosteroids and the prevention of death from asthma Full Text available with Trip Pro

Low dose inhaled corticosteroids and the prevention of death from asthma 11514710 2001 10 04 2018 11 13 0040-6376 56 Suppl 2 2001 Sep Thorax Thorax Low dose inhaled corticosteroids and the prevention of death from asthma. ii74-8 Kips J C JC Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. johan.kips@rug.ac.be Pauwels R A RA eng Journal Article Review England Thorax 0417353 0040-6376 0 Anti-Inflammatory Agents 0 Glucocorticoids IM (...) Administration, Inhalation Administration, Topical Anti-Inflammatory Agents therapeutic use Asthma drug therapy mortality Drug Administration Schedule Glucocorticoids Humans Survival Rate 93 2001 8 22 10 0 2001 10 5 10 1 2001 8 22 10 0 ppublish 11514710 PMC1765979 Bull Int Union Tuberc. 1976;51(1):267-9 1030295 Br Med J. 1979 Nov 10;2(6199):1199-201 519358 Br Med J. 1980 Mar 8;280(6215):687-90 7363023 Am Rev Respir Dis. 1981 Jan;123(1):104-9 7458072 Life Sci. 1980 Nov 24;27(21):1985-90 6111007 Thorax. 1983

2001 Thorax

28248. Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips Full Text available with Trip Pro

Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips 11431303 2001 07 26 2018 11 13 0959-8138 322 7302 2001 Jun 30 BMJ (Clinical research ed.) BMJ Lesson of the week: Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. 1589-91 Nasser S M SM Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, Cambridge CB2 2QQ. Ewan P W PW eng Case Reports Journal Article England BMJ 8900488 0959-8138 0 Anti (...) -Inflammatory Agents 0 Delayed-Action Preparations 0 Glucocorticoids 1ZK20VI6TY Triamcinolone X4W7ZR7023 Methylprednisolone AIM IM Administration, Topical Adult Anti-Inflammatory Agents administration & dosage adverse effects Delayed-Action Preparations adverse effects Femur Head Necrosis chemically induced complications diagnostic imaging Glucocorticoids Humans Immunotherapy Male Methylprednisolone administration & dosage adverse effects Radiography Rhinitis, Allergic, Seasonal complications drug therapy

2001 BMJ : British Medical Journal

28249. Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease Full Text available with Trip Pro

Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease 10943634 2000 08 21 2018 11 13 0040-6376 55 Suppl 1 2000 Aug Thorax Thorax Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease. S23-7 Wedzicha J A JA Academic Respiratory Medicine, St Bartholomew's and Royal London School of Medicine and Dentistry, St Bartholomew's Hospital, UK. eng Journal Article Review England Thorax 0417353 0040-6376 0 Glucocorticoids 9PHQ9Y1OLM Prednisolone IM (...) Administration, Oral Forced Expiratory Volume drug effects Glucocorticoids administration & dosage therapeutic use Humans Lung physiopathology Lung Diseases, Obstructive drug therapy physiopathology Prednisolone administration & dosage therapeutic use Randomized Controlled Trials as Topic Recurrence 40 2000 8 16 11 0 2000 8 29 11 1 2000 8 16 11 0 ppublish 10943634 PMC1765946 Thorax. 1999 Dec;54 Suppl 3:A1-89 10619051 Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1635-9 10556133 Am Rev Respir Dis. 1976 Apr

2000 Thorax

28250. Inhaled corticosteroid dosage in asthma Full Text available with Trip Pro

Inhaled corticosteroid dosage in asthma 12200533 2002 10 01 2008 11 20 0040-6376 57 9 2002 Sep Thorax Thorax Inhaled corticosteroid dosage in asthma. 837-8; author reply 838 Reddel H K HK Marks G B GB Salome C M CM Jenkins C R CR eng Comment Letter England Thorax 0417353 0040-6376 0 Adrenal Cortex Hormones 0 Anti-Inflammatory Agents 0 Glucocorticoids 51333-22-3 Budesonide IM Thorax. 2002 Apr;57(4):309-16 11923548 Administration, Topical Adrenal Cortex Hormones administration & dosage Anti

2002 Thorax

28251. Physiotherapy or corticosteroid injection for shoulder pain? Full Text available with Trip Pro

Physiotherapy or corticosteroid injection for shoulder pain? 12695146 2003 05 22 2018 11 13 0003-4967 62 5 2003 May Annals of the rheumatic diseases Ann. Rheum. Dis. Physiotherapy or corticosteroid injection for shoulder pain? 385-7 van der Windt D A W M DA Bouter L M LM eng Journal Article England Ann Rheum Dis 0372355 0003-4967 0 Adrenal Cortex Hormones IM Ann Rheum Dis. 2004 Jan;63(1):111; author reply 111-2 14672908 Adrenal Cortex Hormones therapeutic use Humans Pain Measurement methods (...) Patient Satisfaction Physical Therapy Modalities Randomized Controlled Trials as Topic Reproducibility of Results Shoulder Pain drug therapy therapy Time Factors Treatment Outcome 2003 4 16 5 0 2003 5 23 5 0 2003 4 16 5 0 ppublish 12695146 PMC1754536 J Clin Epidemiol. 2000 Jan;53(1):29-38 10693901 J Orthop Sports Phys Ther. 2000 Mar;30(3):126-37 10721508 J Clin Epidemiol. 2000 Feb;53(2):163-6 10729688 Br J Gen Pract. 2000 May;50(454):371-4 10897533 Ann Intern Med. 2001 May 1;134(9 Pt 2):889-97

2003 Annals of the Rheumatic Diseases

28252. Double-blind corticosteroid trial in identical twins following photorefractive keratectomy. (Abstract)

Double-blind corticosteroid trial in identical twins following photorefractive keratectomy. The use of topical corticosteroids following excimer laser photorefractive keratectomy (PRK) is widespread, but the role of corticosteroids remains poorly defined. The purpose of this study was to evaluate the use of different corticosteroid postoperative regimens following 193-nanometer excimer PRK in identical twins. Preoperatively, cycloplegic refraction of the left eye of each twin measured -3.00 D (...) presented a unique opportunity to better understand wound healing following laser keratectomy. The results of this limited study indicated that for at least lower degrees of myopia the need for full strength topical corticosteroids remains questionable.

1993 Refractive & corneal surgery Controlled trial quality: uncertain

28253. The effects of phonophoresis with corticosteroids: a controlled pilot study. (Abstract)

The effects of phonophoresis with corticosteroids: a controlled pilot study. Although physical therapists and physicians often treat patients with local musculoskeletal inflammation using topically applied steroids enhanced with ultrasound, there is a paucity of research confirming that phonophoresis significantly enhances drug diffusion. The purpose of this study was to determine if ultrasound enhances the diffusion of transdermally applied corticosteroids. Diffusion was measured secondarily

1993 The Journal of orthopaedic and sports physical therapy Controlled trial quality: uncertain

28254. A corticosteroid, a non-steroidal anti-inflammatory drug and an antihistamine modulate in vivo vascular reactions before and during post-occlusive hyperaemia. (Abstract)

A corticosteroid, a non-steroidal anti-inflammatory drug and an antihistamine modulate in vivo vascular reactions before and during post-occlusive hyperaemia. Post-occlusive reactive hyperaemia is the temporary increase of blood flow in a tissue following transient vascular obstruction, and has recently been proposed as an in vivo method for ranking topical corticosteroid potency. We investigated in vivo vascular reactions before and during post-occlusive hyperaemia using laser-Doppler (...) flowmetry and reflectance spectroscopy (RS). RS enables resolution of in vivo erythema into deoxygenated (venous) [DOH] and oxygenated (arterial) haemoglobin (OH) components (expressed in arbitrary units, AU). Using a randomized 24-h occlusive exposure in 10 healthy volunteers the effects of a corticosteroid (betamethasone-17-valerate), a non-steroidal anti-inflammatory drug (NSAID) [indomethacin], an antihistamine (diphenhydramine), or vehicle, were studied before and during post-occlusive hyperaemia

1993 The British journal of dermatology Controlled trial quality: uncertain

28255. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. (Abstract)

at baseline improved when patients were weaned off oral prednisone to fluticasone propionate. Adverse events ascribed to drug treatment were primarily topical effects of inhaled corticosteroids or those associated with prednisone withdrawal. Patient quality of life assessed by means of the Asthma Quality of Life Questionnaire was clinically and significantly improved after fluticasone propionate treatment (P adrenal function, and asthma-specific quality of life in patients with severe chronic asthma previously treated with oral prednisone while allowing most patients to be weaned off oral corticosteroid therapy.

1999 The Journal of allergy and clinical immunology Controlled trial quality: predicted high

28256. Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. (Abstract)

Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. The effect of long-term topical nasal corticosteroid therapy on nasal inflammatory cells is unclear.To investigate the long-term effect of fluticasone propionate aqueous nasal spray (FPANS) on nasal mucosal inflammatory cells and efficacy in a 1-year study in patients with perennial allergic rhinitis.In a 1-year, double-blind, placebo-controlled study of duration we (...) investigated the influence of a topical corticosteroid (FPANS), on Langerhans' cells (CD1a+ cells), T cells, mast cells, eosinophils and macrophages in nasal mucosa in 42 patients with perennial allergic rhinitis. Efficacy was evaluated by nasal symptom score.The FPANS group experienced significantly less sneezing and nasal itching compared with the placebo group. The total symptom score in the FPANS group declined significantly in comparison with baseline (P = 0.007) and placebo group (P = 0.009). After 1

1999 Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology Controlled trial quality: uncertain

28257. Postural skin colour changes during the corticosteroid blanching assay. (Abstract)

Postural skin colour changes during the corticosteroid blanching assay. To assess the effect of the position of a limb (dependency) on the cutaneous vasoconstrictor (blanching) assay (VCA) using topical corticosteroid preparations.Two studies were performed on the forearms of healthy volunteers using tristimulus reflectance colorimetric assessments. The first one conducted in 60 normal adults aimed at quantifying the range of variation in the skin chromaticity a* when the arm was successively (...) variations in skin colour varied among subjects. The majority of them (80%) presented a difference in a* higher than 2 units between the upright and downward arm positions. The upright position appeared to be the most sensitive to show significant differences in the VCA. Mometasone furoate exhibited the most prominent effect, significantly higher than betamethasone valerate and controls.The corticosteroid VCA is influenced by the position of the limb. The upright position increases the sensitivity

1999 Skin pharmacology and applied skin physiology Controlled trial quality: uncertain

28258. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate. (Abstract)

The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate. Two studies were conducted using the conjunctival provocation test (CPT) model of ocular allergy. The objective of the first study was to evaluate the sensitivity of the CPT model to a topical corticosteroid. Selected was loteprednol etabonate 0.5%, previously found effective in the treatment of ocular allergy and inflammation. The study was a randomized double (...) in the evaluation of corticosteroids. Furthermore, based upon a dose-response study in this model, 0.2% loteprednol etabonate was selected for further evaluation in environmental seasonal allergic conjunctivitis studies.

1998 Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics Controlled trial quality: uncertain

28259. Efficacy of corticosteroids in acute experimental irritant contact dermatitis? (Abstract)

Efficacy of corticosteroids in acute experimental irritant contact dermatitis? Topical corticoids are used to treat irritant contact dermatitis (ICD) in humans. However, their clinical efficacy remains sub judice. This study was designed to assess the efficacy of low- and medium-potency corticosteroids on irritant dermatitis.We induced an acute ICD via open application of sodium lauryl sulphate (SLS) on the hands of subjects. The dorsal side of hands was irritated with 10% SLS five times in one

2001 Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) Controlled trial quality: uncertain

28260. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. (Abstract)

groups.Adding MMF, a potent topical corticosteroid, to an emollient cream is statistically significantly more effective than emollient cream alone in reducing acute radiation dermatitis. (...) Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiation-induced dermatitis is a very common side effect of radiation therapy, and may necessitate interruption of the therapy. There is a substantial lack of evidence-based treatments for this condition. The aim of this study was to investigate the effect of mometasone furoate cream (MMF) on radiation dermatitis in a prospective, double-blind

2001 Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>